Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Company Overview and Business Segments
CHE logo

Chemed Corp's Net Income Surges 10.8% to $302M on VITAS Hospice Boom

CHE10-KFiling Date: 2/28/2025
Chemed Corporation
Description

What this story covers

Chemed Corp reported 2024 net income of $302M, up 10.8%, driven by 16.4% VITAS revenue growth to $1.53B amid higher admissions, offsetting Roto-Rooter's 5.2% decline. Adjusted EBITDA rose 11.3% to $503M. Strong cash flow of $417.5M funded $361M buybacks and $85M Covenant acquisition. Risks include Medicare reliance and competition. Outlook: EPS $24.94-25.45.

Story snapshot

CompanyChemed Corporation
TickerCHE
VariantStandard detailed
Duration11:38
Filing type10-K
PeriodAnnual 2024
IndustryHealthcare & Pharmaceuticals
Accession0001562762-25-000038

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in